---
title: "Cosciens Biopharma shareholders approve share capital amendment at annual meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290198432.md"
description: "Cosciens Biopharma shareholders approved a share capital amendment at their June 18, 2026 annual meeting, authorizing a 1-for-150 consolidation followed by a 50-for-1 split. The company also re-appointed Deloitte LLP as auditor and appointed Peter H. Puccetti as permanent CEO. While the amendment was authorized, execution has not been confirmed."
datetime: "2026-06-18T12:30:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290198432.md)
  - [en](https://longbridge.com/en/news/290198432.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290198432.md)
generator: "portal-rs"
---

# Cosciens Biopharma shareholders approve share capital amendment at annual meeting

-   Cosciens Biopharma held its annual general and special shareholder meeting on June 18, 2026. \* Shareholders adopted the re-appointment of Deloitte LLP as auditor. \* Shareholders authorized a share capital amendment: a 1-for-150 common-share consolidation, followed immediately by a 50-for-1 split. \* The share capital amendment was authorized at the meeting; the company has not confirmed the consolidation or split has been executed. \* Peter H. Puccetti was appointed permanent full-time president and CEO, effective immediately, following his interim CEO role since November. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosciens Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606180830PRIMZONEFULLFEED9749058) on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CSCI.US](https://longbridge.com/en/quote/CSCI.US.md)
- [CSCIF.US](https://longbridge.com/en/quote/CSCIF.US.md)
- [CSCID.US](https://longbridge.com/en/quote/CSCID.US.md)

## Related News & Research

- [Cosciens Biopharma deregisters common shares with SEC, ends US reporting obligations](https://longbridge.com/en/news/291841639.md)
- [Betterware de Mexico director Juan Jose Pajon files initial beneficial ownership statement](https://longbridge.com/en/news/297097512.md)
- [WSM: Leading specialty home furnishings with $7.8B revenue, digital-first growth, and strong returns](https://longbridge.com/en/news/297047258.md)
- [SYNSAM: Double-digit sales and profit growth in Q2, with strong margins and expanding subscriptions](https://longbridge.com/en/news/296571574.md)
- [WSM: Q2 delivered strong revenue and margin growth, with raised 2026 guidance and robust liquidity](https://longbridge.com/en/news/297043057.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**